Securing dose quality of inhalable drug
Details for Australian Patent Application No. 2005251670 (hide)
International Classifications
Event Publications
4 January 2007 PCT application entered the National Phase
PCT publication WO2005/120616 Priority application(s): WO2005/120616
22 April 2010 Application Accepted
Published as AU-B-2005251670
2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
4 August 2011 Corrigenda
Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2005 Delete all reference to Application No. 2005251670.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005251673-Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser